105 related articles for article (PubMed ID: 11808322)
1. [beta 3-adrenergic receptor agonists as anti-obese and anti-diabetic drugs].
Sakura H; Togashi M; Iwamoto Y
Nihon Rinsho; 2002 Jan; 60(1):123-9. PubMed ID: 11808322
[TBL] [Abstract][Full Text] [Related]
2. [Beta 3 adrenergic receptor agonist].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():712-8. PubMed ID: 12430307
[No Abstract] [Full Text] [Related]
3. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
Weyer C; Gautier JF; Danforth E
Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
[TBL] [Abstract][Full Text] [Related]
4. Effects of Trecadrine, a beta3-adrenergic agonist, on leptin secretion, glucose and lipid metabolism in isolated rat adipocytes.
Moreno-Aliaga MJ; Martínez JA; Stanhope KL; Fernández-Otero MP; Havel PJ
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):912-9. PubMed ID: 12080443
[TBL] [Abstract][Full Text] [Related]
5. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice.
Fu L; Isobe K; Zeng Q; Suzukawa K; Takekoshi K; Kawakami Y
Eur J Pharmacol; 2008 Apr; 584(1):202-6. PubMed ID: 18304529
[TBL] [Abstract][Full Text] [Related]
6. Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
de Souza CJ; Burkey BF
Curr Pharm Des; 2001 Sep; 7(14):1433-49. PubMed ID: 11472270
[TBL] [Abstract][Full Text] [Related]
7. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.
Arch JR
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):225-40. PubMed ID: 18612674
[TBL] [Abstract][Full Text] [Related]
8. beta(3)-Adrenoceptor agonists: potential, pitfalls and progress.
Arch JR
Eur J Pharmacol; 2002 Apr; 440(2-3):99-107. PubMed ID: 12007528
[TBL] [Abstract][Full Text] [Related]
9. [Insulin resistance and beta 3-adrenergic receptor function].
Kobayashi I; Ishigami T; Umemura S
Nihon Rinsho; 2000 Feb; 58(2):333-7. PubMed ID: 10707554
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats.
Gómez-Ambrosi J; Frühbeck G; Aguado M; Milagro FI; Margareto J; Martínez AJ
Int J Mol Med; 2001 Jul; 8(1):103-9. PubMed ID: 11408957
[TBL] [Abstract][Full Text] [Related]
11. Effects of a beta3-adrenergic agonist on glucose uptake and leptin expression and secretion in cultured adipocytes from lean and overweight (cafeteria) rats.
Moreno-Aliaga MJ; Lamas O; Marti A; Martínez JA
Biochem Biophys Res Commun; 2002 Mar; 291(5):1201-7. PubMed ID: 11883944
[TBL] [Abstract][Full Text] [Related]
12. The beta 3-adrenoceptor: physiological role and potential therapeutic applications.
Balligand JL
Acta Clin Belg; 2000; 55(4):209-14. PubMed ID: 11036679
[No Abstract] [Full Text] [Related]
13. Antiobesity and antidiabetic beta-agonists: lessons learned and questions to be answered.
Yen TT
Obes Res; 1994 Sep; 2(5):472-80. PubMed ID: 16353599
[TBL] [Abstract][Full Text] [Related]
14. The beta3-adrenergic agonist CL316,243 inhibits insulin signaling but not glucose uptake in primary human adipocytes.
Jost MM; Jost P; Klein J; Klein HH
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):418-22. PubMed ID: 16151974
[TBL] [Abstract][Full Text] [Related]
15. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes.
Gettys TW; Harkness PJ; Watson PM
Endocrinology; 1996 Sep; 137(9):4054-7. PubMed ID: 8756584
[TBL] [Abstract][Full Text] [Related]
16. Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells.
Hoffstedt J; Näslund E; Arner P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3362-7. PubMed ID: 12107250
[TBL] [Abstract][Full Text] [Related]
17. Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes.
Hu B; Jennings LL
Prog Med Chem; 2003; 41():167-94. PubMed ID: 12774694
[No Abstract] [Full Text] [Related]
18. Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol.
Ren T; He J; Jiang H; Zu L; Pu S; Guo X; Xu G
J Mol Endocrinol; 2006 Aug; 37(1):175-83. PubMed ID: 16901933
[TBL] [Abstract][Full Text] [Related]
19. Regulation of leptin release by insulin, glucocorticoids, G(i)-coupled receptor agonists, and pertussis toxin in adipocytes and adipose tissue explants from obese humans in primary culture.
Kanu A; Fain JN; Bahouth SW; Cowan GS
Metabolism; 2003 Jan; 52(1):60-6. PubMed ID: 12524663
[TBL] [Abstract][Full Text] [Related]
20. Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice.
Collins S; Daniel KW; Petro AE; Surwit RS
Endocrinology; 1997 Jan; 138(1):405-13. PubMed ID: 8977430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
